| CRPC | Castration Resistant Prostate Cancer |
| HDAC | Histone Deacetylase |
| HAT | Histone Acetyl Transferase |
| DNA | Deoxyribonucleic Acid |
| NF- kB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| FoxO1 | Forkhead box protein O1 |
| PSA | Prostate Specific Antigen |
| HSP-90 | Heat Shock Protein-90 |
| SAHA | Suberoylanilide Hydroxamic acid |
| IL6 | Interleukin 6 |
| LBH589 | Panobinostat |
| LAQ824 | Dacinostat |
| FDA | Food and Drug Administration |
| AR | Androgen Receptor |
| RECIST | Response Evaluation Criteria in Solid Tumors |
| CTC | Circulating Tumor Cell |
| ERG | ETS-related Gene |
| PTEN | Phosphatase and Tensin homolog |
| NE | Neuroendocrine |
| FGF-8 | Fibroblast Growth Factor-8 |
| MAPK | Mitogen-Activated Protein Kinase |
| EMT | Epithelial-Mesenchymal Transition |
| ZEB1 | Zinc finger E-box-binding homeobox 1 |
| MMP2 | Matrix Metalloproteinase-2 |
| TSA | Trichostatin A |
| VPA | Valproic Acid |
| HIF-1α | Hypoxia-inducible Factor 1-alpha |
| VEGFR-2 | Vascular Endothelial Growth Factor Receptor 2 |
| PEDF | Pigment Epithelium-derived Factor |
| KLF-4 | Kruppel-like Factor 4 |
| ChIP | Chromatin immunoprecipitation |
| FGF2 | Fibroblast Growth Factor 2 |
| PDGF-B | Platelet-derived Growth Factor Beta |
| MEF2 | Myocyte Enhancer Factor-2 |
| CSC | Cancer Stem-like Cells |
| AMP | Adenosine Monophosphate |
| CREB | cAMP Response Element-binding Protein |
| PTPN22 | Protein Tyrosine Phosphatase, Non-receptor type 22 |
| MMR | Mismatch Repair |
| WNT | Wingless-related Integration Site |
| PPAR | Peroxisome Proliferator-activated Receptor |
| BMP-4 | Bone Morphogenetic Protein 4 |
| P-Gp | P-Glycoproteins |
| MDR1 | Multi-drug Resistance-1 |
| CsA | Cyclosporin A |
| TRAMP | Transgenic Adenocarcinoma of the Mouse Prostate |
| MD | Moderately Differentiated |